dc.contributor.author | Frutos, Fernando de | es_ES |
dc.contributor.author | Ochoa, Juan Pablo | es_ES |
dc.contributor.author | Navarro-Peñalver, Marina | es_ES |
dc.contributor.author | Baas, Annette | es_ES |
dc.contributor.author | Vandborg, Bjerre | es_ES |
dc.contributor.author | Zorio, Esther | es_ES |
dc.contributor.author | Méndez, Irene | es_ES |
dc.contributor.author | Lorca, Rebeca | es_ES |
dc.contributor.author | Verdonschot, Job AJ. | es_ES |
dc.contributor.author | García-Granja, Pablo Elpidio | es_ES |
dc.contributor.author | Bilinska, Zofia | es_ES |
dc.contributor.author | Fatkin, Diane | es_ES |
dc.contributor.author | Fuentes-Cañamero, M. Eugenia | es_ES |
dc.contributor.author | García-Pinilla, José M. | es_ES |
dc.contributor.author | García-Álvarez, María I. | es_ES |
dc.contributor.author | Girolami, Francesca | es_ES |
dc.contributor.author | Barriales-Villa, Roberto | es_ES |
dc.contributor.author | Díez-López, Carles | es_ES |
dc.contributor.author | Lopes, Luis R. | es_ES |
dc.contributor.author | Ruiz Guerrero, Luis Javier | es_ES |
dc.contributor.other | Universidad de Cantabria | es_ES |
dc.date.accessioned | 2023-02-24T15:14:38Z | |
dc.date.available | 2023-09-01T02:15:33Z | |
dc.date.issued | 2022-08-22 | es_ES |
dc.identifier.issn | 0735-1097 | es_ES |
dc.identifier.issn | 1558-3597 | es_ES |
dc.identifier.uri | https://hdl.handle.net/10902/27869 | |
dc.description.abstract | Background
Variants in MYH7 are responsible for disease in 1-5% of patients with dilated cardiomyopathy (DCM); however, the clinical characteristics and natural history of MYH7-related DCM are poorly described.
Objectives
We sought to determine the phenotype and prognosis of MYH7-related DCM. We also evaluated the influence of variant location on phenotypic expression.
Methods
We studied clinical data from 147 individuals with DCM-causing MYH7 variants (47.6% females, 35.6±19.2 years) recruited from 29 international centers.
Results
At initial evaluation, 106 patients (72.1%) had DCM (LVEF 34.5±11.7%). Median follow-up was 4.5 years (interquartile range: 1.7-8.0) and 23.7% of carriers who were initially phenotype-negative developed DCM. Phenotypic expression by 40 and 60 years was 46% and 88%, respectively, with 18 patients (16%) first diagnosed at <18 years. Thirty-six percent of patients with DCM met imaging criteria for LV non-compaction. During follow-up, 28% showed left ventricular reverse remodeling (LVRR). Incidence of adverse cardiac events among patients with DCM at 5 years was 11.6%, with 5 (4.6%) deaths due to end-stage heart failure (ESHF) and 5 patients (4.6%) requiring heart transplantation. The major ventricular arrhythmia (MVA) rate was low (1.0% and 2.1% at 5 years in patients with DCM and in those with LVEF?35%, respectively). ESHF and MVA were significantly lower compared with LMNA-related DCM and similar than in DCM caused by TTN truncating variants.
Conclusions
MYH7-related DCM is characterized by early age of onset, high phenotypic expression, low LVRR, and frequent progression to ESHF. Heart failure complications predominate over ventricular arrhythmias, which are rare. | es_ES |
dc.description.sponsorship | Funding: This study has been funded by Instituto de Salud Carlos III (ISCIII) through the projects "PI18/0004, PI20/0320, PT17/0015/0043” (Co-funded by European Regional Development Fund/European Social Fund "A way to make Europe"/"Investing in your future"). The CNIC is supported by the ISCIII, MCIN, the Pro-CNIC Foundation, and the Severo Ochoa Centers of Excellence program (CEX2020-001041-S). The Hospital Universitario Puerta de Hierro, the Hospital Sant Joan de Déu and the Hospital Universitario Virgen de la Arrixaca are members of the European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart (http://guardheart.ernnet.eu). Fernando de Frutos receives grant support from ISCIII (CM20/00101). Annette Baas receives funding from CVON2020B005 DOUBLE-DOSE, Dutch Heart Foundation (Dekker 2015T041). Genetic examinations of Polish patients were funded with DETECTIN-HF grant from ERA-CVD framework, NCBiR. Diane Fatkin receives funding from Victor Chang Cardiac Research Institute and NSW Health. Luis R Lopes is funded by an MRC UK Clinical Academic Research Partnership award (MR/T005181/1). Benjamin Meder receives funding from the Deutsches Zentrum für Herz-Kreislauf-Forschung (German Center for Cardiovascular Research, DZHK) and Informatics for Life (Klaus Tschira Foundation). Milos Kubankek receives grant support from the Ministry of Health, Czech Republic (NV19-08-00122) and IPO (Institute for Clinical and Experimental Medicine – IKEM, IN 00023001). | es_ES |
dc.format.extent | 43 p. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Elsevier | es_ES |
dc.rights | © 2022 The authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY -NC-ND license | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.source | Journal of the American College of Cardiology, 2022, 80 (15) 1447–1461 | es_ES |
dc.subject.other | MYH7 | es_ES |
dc.subject.other | Dilated cardiomyopathy | es_ES |
dc.subject.other | Genetics | es_ES |
dc.title | Natural History of MYH7-related Dilated Cardiomyopathy | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.relation.publisherVersion | https://doi.org/10.1016/j.jacc.2022.07.023 | es_ES |
dc.rights.accessRights | openAccess | es_ES |
dc.identifier.DOI | 10.1016/j.jacc.2022.07.023 | es_ES |
dc.type.version | publishedVersion | es_ES |